A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK
-
* Corresponding author: Monique Martin monique.martin@i3innovus.com
Cost Effectiveness and Resource Allocation 2010, 8:7 doi:10.1186/1478-7547-8-7
Accesses
- Last 30 days: 115 accesses
- Last 365 days: 1304 accesses
- All time: 3549 accesses